2025年2月4日 · Eprex 40000 IU/ml solution for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

EPREX injection is a clear, colourless solution in prefilled syringes of 1000 IU in 0.5 mL, 2000 IU in 0.5 mL, 3000 IU in 0.3 mL, 4000 IU in 0.4 mL, 5000 IU in 0.5 mL, 6000 IU in 0.6 mL, 8000 IU in 0.8 mL, 10000 IU in

2025年1月7日 · Eprex or exogenous epoetin alfa binds to the erythropoietin receptor (EPO-R) and activates intracellular signal transduction pathways . The affinity (Kd) of EPO for its receptor …

EPREX should be used with caution in patients with epilepsy, history of seizures, or medical conditions associated with a predisposition to seizure activity such as CNS infections and brain metastases.

Patient information for EPREX 4 000 IU/ML SOLUTION FOR INJECTION IN PFS Including dosage instructions and possible side effects.

2025年1月30日 · Eprex 10000 IU/ml solution for injection in pre-filled syringe - Patient Information Leaflet (PIL) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

Patients with uncontrolled hypertension should not be treated with Eprex; blood pressure should be controlled adequately before initiation of therapy. Eprex should be used with caution in patients with a history of seizures. Antibody-mediated pure red cell aplasia (PRCA) has been reported after of treatment with ESAs.

EPREX is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion. EPREX can reduce the need for a blood transfusion in these patients.

Patient Information leaflet PRODUCT NAME EPREX (Epoetinum alfa) Pre-filled Syringe DOSAGE FORMS AND STRENGTHS Epoetinum alfa, a glycoprotein produced by recombinant DNA technology, is the active ingredient. Epoetinum alfa is a sterile, clear, colorless, buffered parenteral solution for intravenous or subcutaneous injection.

EPREX is prescribed to stimulate your bone marrow to produce more red blood cells. EPREX is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion. EPREX can reduce the need for a blood transfusion in these patients.